Data / Form D filings / Iaso Therapeutics, Inc.
Iaso Therapeutics, Inc.: Form D filings
Iaso Therapeutics, Inc., a biotechnology company in East Lansing, MI, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on January 14, 2026, reports $570,000 sold of a $1.8 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4942 DAWN AVE STE 108, East Lansing, MI, 48823
- Phone
- (773) 437-0274
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1961165
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | New notice | $1,800,000 | $570,000 | $1,230,000 | 1 | Jan 9, 2026 | sec.gov |
| Jan 6, 2023 | New notice | $1,337,850 | $437,850 | $900,000 | 5 | Dec 22, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Forgey | Executive Officer, Director | |
| Xuefei Huang | Executive Officer, Director | |
| Steve Kuemmerie | Director | |
| Jeffrey Wesley | Director | |
| Donald Parfet | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Jan 12, 2026 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Iaso Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.